Latest news with #RIG
Yahoo
17 hours ago
- Business
- Yahoo
Transocean (RIG) Falters For 3rd Straight Day – Here's Why
We recently published a list of 10 Stocks Take A Shocking Nosedive. Transocean Ltd. (NYSE:RIG) is one of the worst-performing stocks on Thursday. Transocean dropped by 3.74 percent on Wednesday to close at $3.09 apiece as investors unloaded portfolios over the lack of fresh developments to boost buying. Wednesday's share price marked its third straight day of decline, suggesting that investors have already priced in earlier news that it secured another $100 million contract with existing client, Equinor ASA. Under the agreement, Transocean Ltd. (NYSE:RIG) will drill two more wells for Equinor ASA at the Spitsbergen rig in Norway as part of the latter's drilling extension option. The program is expected to kick off in the first quarter of 2026 in direct continuation of the rig's current program. The additional work followed their original three-well program on the Norwegian Continental Shelf (NCS), which was procured in 2024. An aerial view of an oil rig with drillers in hard hats working on the platform. Transocean Ltd.'s (NYSE:RIG) Spitsbergen rig was built in 2010 as a sixth-generation dual-derrick winterized semi-submersible rig, which is capable of drilling high-pressure and high-temperature formations. While we acknowledge the potential of RIG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
6 days ago
- Business
- Yahoo
Transocean Ltd (RIG) Soars on New $100M Contract
We recently published a list of . In this article, we are going to take a look at where Transocean Ltd. (NYSE:RIG) stands against other top-performing companies on Tuesday. Transocean Ltd. grew its share prices by 7.32 percent on Tuesday to close at $3.08 apiece as investors cheered worth $100 million of backlogs after its client, Equinor ASA, exercised the option to extend its drilling operations at the Spitsbergen rig in Norway. In a statement, Transocean Ltd. (NYSE:RIG) said Equinor exercised a two-well option for the Transocean Spitsbergen in Norway. The program is expected to kick off in the first quarter of the year in direct continuation of the rig's current program. The additional work followed their original there-well program on the Norwegian Continental Shelf (NCS), which was procured in 2024. The Transocean Spitsbergen was built in 2010 as a sixth-generation dual-derrick winterized semi-submersible rig, which is capable of drilling high-pressure and high-temperature formations. An aerial view of an oil rig with drillers in hard hats working on the platform. In the first quarter of the year, Transocean Ltd. (NYSE:RIG) swung to a net loss of $79 million from a net income of $98 million in the same period a year earlier, despite contract drilling revenues improving by 18.7 percent to $906 million from $763 million year-on-year. Overall, RIG ranks 4th on our list of top-performing companies on Tuesday. While we acknowledge the potential of RIG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Forbes
11-06-2025
- Business
- Forbes
RIG Stock: Low Valuation But High Risk?
Transocean (NYSE:RIG), a company specializing in offshore drilling, has significantly lagged behind the broader S&P 500 index over the last twelve months, posting a decline of 45% compared to the S&P 500's increase of 12%. The firm is currently facing financial setbacks, worsened by escalating cost inflation. Its overall financial condition seems fragile, and a slowdown in economic growth is anticipated to further diminish the demand for new oil and gas exploration initiatives. Despite appearing to have a very low valuation, there remain several major concerns about RIG stock. In this analysis, we present a thorough comparison of Transocean's current valuation with its operational performance in recent years, along with an evaluation of its current and historical financial status. That said, if you are looking for upside with less volatility compared to individual stocks, the Trefis High Quality portfolio offers an alternative — it has outperformed the S&P 500 and generated returns exceeding 91% since its launch. Separately, see – QBTS Stock: What's Next For D-Wave After 1,350% Rally? From a valuation standpoint, Transocean stock presently seems low-priced when evaluated against its sales or profit. The company's price-to-sales (P/S) ratio is at 0.7, considerably lower than the S&P 500's ratio of 3.0. Likewise, Transocean's price-to-free cash flow (P/FCF) ratio stands at 5.7, significantly beneath the S&P 500's 20.5. Notwithstanding its low valuation, Transocean has shown substantial revenue growth in recent years. Over the past three years, its top-line revenue has grown at an average annual rate of 11.7%, outpacing the S&P 500's increase of 5.5%. More recently, Transocean's revenues surged by 24.4%, rising from $2.9 billion to $3.7 billion in the past twelve months, compared to the S&P 500's growth of 5.5%. In the most recent quarter, quarterly revenues experienced a significant increase of 18.7%, climbing to $906 million from $763 million a year earlier, greatly exceeding the S&P 500's improvement of 4.8%. However, the profitability indicators of Transocean present a stark contrast to its revenue growth. The company's profit margins are weaker than those of most firms within the Trefis coverage universe. Over the last four quarters, Transocean reported an Operating Income of $431 million, leading to a modest Operating Margin of 11.7%, which is lower than the S&P 500's 13.2%. Additionally, its Operating Cash Flow (OCF) for the same period was $559 million, which translates to a moderate OCF Margin of 15.2% when compared with the S&P 500's 14.9%. The most alarming figure is Transocean's Net Income over the last four quarters, which showed a loss of $728 million, indicating a very poor Net Income Margin of -19.9% against the S&P 500's positive 11.6%. The financial stability of Transocean appears quite weak. As of the latest quarter, the company's debt amounted to $6.6 billion, while its market capitalization stood at $2.7 billion (as of June 10, 2025). This results in a very poor Debt-to-Equity Ratio of 244%, significantly higher than the S&P 500's 19.9%, suggesting a heavily leveraged balance sheet. Furthermore, cash and cash equivalents make up only $263 million of Transocean's total assets of $19 billion, producing a poor Cash-to-Assets Ratio of 2.9%, which is markedly below the S&P 500's 13.8%. Transocean's stock has also been less resilient compared to the S&P 500 index during recent market downturns. For instance, amidst the Inflation Shock of 2022, RIG stock tumbled 53.5% from its peak of $5.08 on July 2, 2021, to $2.36 on September 23, 2022, representing a more significant decline than the S&P 500's peak-to-trough decrease of 25.4%. Although the stock fully recovered to its pre-crisis peak by January 9, 2023, and later rose to $8.80 by July 31, 2023, it is currently trading around $3.10. Similarly, during the COVID-19 Pandemic of 2020, RIG stock experienced a drastic drop of 90.6% from a high of $7.17 on January 6, 2020, to $0.67 on October 30, 2020, significantly exceeding the S&P 500's 33.9% decline. It wasn't until February 7, 2023, that the stock regained its pre-crisis peak. Additionally, during the Global Financial Crisis of 2008, RIG stock fell sharply by 73.8% from $153.00 on May 20, 2008, to $40.04 on December 24, 2008, again a steeper drop compared to the S&P 500's decline of 56.8%. Notably, the stock has yet to return to its pre-crisis high from 2008. In summary, Transocean's performance across these metrics suggests a generally weak outlook. Although its growth has been robust, it is overshadowed by significantly weak profitability and extremely poor financial stability. Its evident lack of resilience during downturns further amplifies the risk. Despite its current very low valuation, we perceive Transocean as a risky choice. From a long-term perspective, the industry-wide shift toward renewable energy and the increasing environmental regulations are likely to continue fueling investor skepticism about the long-term sustainability of fossil fuel-dependent companies like Transocean, thereby hindering its stock price growth. Of course, our assessment could be wrong. A rebound in demand for oil and gas exploration projects could provide substantial benefits to RIG stock. The company is also actively working to streamline its fleet, which entails an expected $1.2 billion impairment charge in Q2 for the disposal of two rigs (GSF Development Driller I and Discoverer Luanda) along with the potential future disposal of two additional rigs (Development Driller III and Discoverer Inspiration). This strategic streamlining could enhance the company's operational efficiency moving forward. Nevertheless, considering the ongoing poor profitability and weak balance sheet, the overall risk associated with Transocean seems high. We believe there are more attractive investment strategies available in the market. Consider Trefis High Quality (HQ) Portfolio which, consisting of 30 stocks, has consistently outperformed the S&P 500 over the past 4-year period. Why is that? As a collective, HQ Portfolio stocks have provided superior returns with reduced risk relative to the benchmark index; less of a roller-coaster experience, as demonstrated in HQ Portfolio performance metrics.
Time of India
11-06-2025
- Health
- Time of India
‘Anti-rabies vaccine is very effective but there are other factors at play'
Rabies remains a formidable public health challenge in India, with around 20,000 annual deaths accounting for 36% of the global toll, according to WHO. In a conversation with Pushpa Narayan, Dr B Sekar, former director of the Pasteur Institute of India in Coonoor which supplies vaccines to the Centre, explains why some bites are more dangerous than others Last month, three children died in Kerala even after rabies shots, raising questions about quality. Why are such deaths happening despite vaccinations? Aren't the vaccines effective? Anti-rabies vaccines are incredibly effective. But, in some cases, they may fail owing to several factors, including the time of vaccination, dosage, and the type of wound care. For instance, if someone is bitten by a rabid animal and has a category 3 wound, then getting the vaccine right away, along with a rabies immunoglobulin shot, is crucial to make treatment 100% effective in preventing the disease. Also, the person must complete the full vaccination course — day 0, 3, 7, 14, and 28 for most intramuscular route vaccinations and day 0, 3, 7, and 28 for most intradermal vaccinations. Many skip vaccinations if they see the wound heal or if they don't see visible wounds, both of which are wrong. What is a category 3 wound? Why is it so serious? Doctors classify wounds into categories to determine appropriate post-exposure treatment for rabies. Category 3 is considered the most severe type of exposure and typically has one or multiple transdermal bites or scratches where the animal's teeth or claws puncture the full thickness of the skin, causing bleeding. Such wounds carry the highest risk of rabies transmission as the virus-laden saliva has a direct pathway into the body's tissues and potentially the nervous system. If the animal licks a person's eyes, nose, mouth, broken skin (or wound), or any other mucous membrane, that's also category 3 exposure. Any direct contact with bats can be very tiny and go unnoticed but is often treated as category 3. The recommended treatment for category 3 exposures involves immediate and thorough wound washing and rabies vaccination, along with a rabies immunoglobulin (RIG) shot which provides the immediate antibodies to neutralise the virus at the wound site, offering crucial passive protection while the body develops its own immune response from the vaccine. Does the bite site play a key role in prevention? Yes, it does. The rabies virus travels along the peripheral nerves to reach the brain through the spinal cord. If a bite is on the head, neck, or face, the virus has a shorter distance to travel, which can lead to a shorter incubation period and faster onset of symptoms. Prompt and aggressive medical response is critical in such cases. Areas with a lot of nerve endings, such as fingers and toes, also pose increased risk as the virus can easily find a nerve to latch on to. Of course, category 3 wounds, deep bites, contamination of mucous membranes, or broken skin allow more direct access for the virus, whereas a superficial scratch or lick on intact skin carries a much lower risk. What about the risk of a higher viral load in the animal? The amount of rabies virus present in the biting animal's saliva directly impacts the likelihood of transmission. An animal in the later stages of rabies (when the virus has multiplied significantly and spread to the salivary glands) will typically have a higher viral load in its saliva. If it bites, more virus particles are introduced into the body and can enter the nervous system to cause infection. This can overwhelm the local immune response much before vaccination takes effect and contribute to a shorter incubation period before symptoms appear. One step to a healthier you—join Times Health+ Yoga and feel the change
Time of India
30-05-2025
- Health
- Time of India
Stray dog bites 10 people in Mettupalayam
COIMBATORE: A stray dog bit ten people at Mani Nagar in Mettupalayam on Thursday night. All of them received treatment in Mettupalayam Government Hospital. While most of them sustained minor injuries, a couple had more severe bite marks and were examined by a surgeon. Tired of too many ads? go ad free now They have since been declared healthy. A health official in the Mettupalayam GH stated that all the victims were vaccinated against rabies. "People with minor bites were administered anti-rabies vaccine (ARV), and those with severe bite marks were given an additional rabies immunoglobulin (RIG). On Friday morning, they were examined by a surgeon. They have been declared safe. No abnormalities have been reported. All ten people were treated as outpatients," the official added. Meanwhile, based on the direction of Mettupalayam municipality commissioner R Amudha, municipality workers started to capture stray dogs for sterilising them. Around five stray dogs were captured on Friday. There is no animal birth control (ABC) centre in Mettupalayam municipality. Recently, the council passed a resolution to establish an ABC centre.
